等待开盘 09-25 09:30:00 美东时间
-0.580
-2.05%
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give t...
09-24 18:01
AI-Powered Drone Technology Is Transforming Emergency Response While Creating a Multi-Billion-Dollar Market Opportunity Market News Updates News Commentary NEW YORK, Aug. 4, 2026 /PRNewswire...
08-04 21:10
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
JP Morgan analyst Tomohiko Sano maintains Perimeter Solutions (NYSE:PRM) with a Overweight and lowers the price target from $50 to $45.
08-03 23:55
Perimeter Solutions (NYSE:PRM) reported quarterly earnings of $0.35 per share which missed the analyst consensus estimate of $0.43 by 18.6 percent. This is a 10.26 percent decrease over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $213.810 milli...
07-31 18:02
今日重点评级关注:HC Wainwright & Co.:维持Rockwell Medical"买入"评级,目标价从2美元升至20美元;Canaccord Genuity:维持创力"买入"评级,目标价从10.5美元升至11美元
07-10 17:36
JP Morgan analyst Tomohiko Sano initiates coverage on Perimeter Solutions (NYSE:PRM) with a Overweight rating and announces Price Target of $50.
07-09 19:44
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
UBS analyst Joshua Spector maintains Perimeter Solutions (NYSE:PRM) with a Buy and raises the price target from $30 to $34.
05-08 06:51